Results 131 to 140 of about 65,576 (316)

Overview of Anemia Among Systemic Lupus Erythematosus Patients in Reproductive Age Women Based on Reticulocyte Hemoglobin Equivalent (RET-He) Level and Reticulocyte Count [PDF]

, 2017
Background: Anemia is a common manifestation found among patients with Systemic Lupus Erythematosus (SLE). It may be caused by iron-deficiency, autoimmune hemolytic, and chronic inflammation. Each anemia has different therapy approachments.
Ghozali, M. (Mohammad), Hamijoyo, L. (Laniyati), Modjaningrat, I. F. (Ismiana), Oehadian, A. (Amaylia)   +3 more
core  

Splenic artery embolization for the management of severe life-threatening warm autoimmune hemolytic anemia

Hematology
Background Urgent splenectomy is recommended for the management of highly transfusion-dependent life-threatening warm autoimmune hemolytic anemia, while for individuals unfit for surgery, splenic embolization is an alternative treatment option.
Aya Egbaria, Naiel Bisharat
doaj   +1 more source

Chilling Complications: A Case of COVID-Associated Cold Autoimmune Hemolytic Anemia (AIHA) [PDF]

Cold Agglutinin disease (CAD) also known as Cold Autoimmune Hemolytic Anemia (AIHA) is a form of autoimmune hemolytic anemia wherein cold agglutinins (IgM autoantibodies against red blood cell (RBC) antigens) bind during cold temperatures causing ...
Coz, Julian, Patel, Kishan
core   +2 more sources

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 449-458, August 2025.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow, Marek Wardecki, Michael Storek, Nancy Wong   +3 more
wiley   +1 more source

Concurrent Atypical Hemolytic Uremic Syndrome and Autoimmune Hemolytic Anemia: a case report

Caspian Journal of Pediatrics, 2018
Background: Atypical hemolytic uremic syndrome (aHUS) is a life-threatening and scarce disorder characterized by acute renal failure and disease, non-immune microangiopathic hemolytic anemia and thrombocytopenia, leading to end-stage renal failure or ...
Sayed Yousef Mojtahedi, Mohammad Kaji Yazdi   +1 more
doaj  

Autoimmune hemolytic anemia: Case review

Anales de Pediatría (English Edition), 2021
Introduction: Autoimmune hemolytic anemia (AIHA) is a rare and generally self-limiting disease in children. Material and methods: A descriptive cross-sectional study was performed in children under 18 years diagnosed with AIHA from January 1997 to July ...
María Nazaret Sánchez, Josune Zubicaray, Elena Sebastián, Eva Gálvez, Julián Sevilla   +4 more
doaj  

Anemia in Antiretroviral Naïve HIV/AIDS Patients: A Study from Eastern India [PDF]

, 2012
Background: Hematological manifestations are common throughout the course of HIV infection. Impact of anemia is the most significant among them. The present study was undertaken to evaluate the etiologies underlying anemia in HIV/AIDS. Methods This was a
Banerjee, A, Bhattacharyya, M, Ghosh, A, Ghosh, B, Pain, S, Pande, A, Saha, S   +6 more
core   +1 more source

Upper gastrointestinal symptoms in autoimmune gastritis. A cross-sectional study [PDF]

, 2017
Autoimmune gastritis is often suspected for its hematologic findings, and rarely the diagnosis is made for the presence of gastrointestinal symptoms. Aims of this cross-sectional study were to assess in a large cohort of patients affected by autoimmune ...
Annibale, Bruno, Carabotti, Marilia, Esposito, Gianluca, Lahner, Edith, Sacchi, MARIA CARLOTTA, Severi, Carola   +5 more
core   +2 more sources

Real‐World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective Study

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Rituximab is used off‐label for treating cold agglutinin disease (CAD) in the United States; however, real‐world data on its use are limited. Methods This study examined (1) treatment patterns, (2) prespecified safety outcomes, and (3) changes in hemolytic markers post rituximab infusion (threshold change from baseline: hemoglobin
Caroline Piatek, Irina Murakhovskaya, Alia Karaouni, Gandarvaka Miles, Sylvie Bozzi, Carrie Heller, Jacqueline Lucia, Reena Patel, Brad Ward, Ronnie Yoo, Morie Gertz   +10 more
wiley   +1 more source

Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction

Pharmacology Research &Perspectives, Volume 13, Issue 4, August 2025.
ABSTRACT Glucose‐6‐phosphate‐dehydrogenase (G6PD) deficiency is a heterogenous disorder that may lead to severe hemolytic events with the ingestion of fava beans and exposure to certain drugs. We report the first case of a 65‐year‐old male with Crohn's disease who developed a hemolytic crisis leading to hospitalization shortly after commencement of ...
Laura Patanè, Giuseppe Costantino, Marco Muscianisi, Clara De Francesco, Anna Viola, Walter Fries   +5 more
wiley   +1 more source